[
  {
    "ts": null,
    "headline": "Cencora Inc. stock outperforms competitors on strong trading day",
    "summary": "Cencora Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=0b5994a38f2ccd811d395381e287e74bf5279b809a28334123526ffe6bab3639",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752684420,
      "headline": "Cencora Inc. stock outperforms competitors on strong trading day",
      "id": 135982136,
      "image": "",
      "related": "COR",
      "source": "MarketWatch",
      "summary": "Cencora Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=0b5994a38f2ccd811d395381e287e74bf5279b809a28334123526ffe6bab3639"
    }
  },
  {
    "ts": null,
    "headline": "ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines",
    "summary": "AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.",
    "url": "https://finnhub.io/api/news?id=bb9f004af89fcbe3f28aaef14c41a6d7495c564644903b82c6d73bfbb183f805",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752683700,
      "headline": "ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines",
      "id": 135993603,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.",
      "url": "https://finnhub.io/api/news?id=bb9f004af89fcbe3f28aaef14c41a6d7495c564644903b82c6d73bfbb183f805"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now",
    "summary": "XRAY gains traction with digital implants, R&D strength, and Q1 margin growth despite softness in Europe.",
    "url": "https://finnhub.io/api/news?id=3ebe88398fedc643c91fed2ea113fe451a174cc6c02e1d55078aa90275a50b43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752683160,
      "headline": "Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now",
      "id": 135993604,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "XRAY gains traction with digital implants, R&D strength, and Q1 margin growth despite softness in Europe.",
      "url": "https://finnhub.io/api/news?id=3ebe88398fedc643c91fed2ea113fe451a174cc6c02e1d55078aa90275a50b43"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Add Inogen Stock to Your Portfolio Now",
    "summary": "Expanding product portfolio and high prospects for POC raise optimism for INGN stock.",
    "url": "https://finnhub.io/api/news?id=d30093c09e5a1a2d738f4985049c4e1534ad4fd0ecce1cdae68f641260d3d00f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752673320,
      "headline": "Here's Why You Should Add Inogen Stock to Your Portfolio Now",
      "id": 135993920,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Expanding product portfolio and high prospects for POC raise optimism for INGN stock.",
      "url": "https://finnhub.io/api/news?id=d30093c09e5a1a2d738f4985049c4e1534ad4fd0ecce1cdae68f641260d3d00f"
    }
  },
  {
    "ts": null,
    "headline": "GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain?",
    "summary": "Globus Medical debuts DuraPro with Excelsius integration, boosting its Power Portfolio.",
    "url": "https://finnhub.io/api/news?id=8354667fc340f432e5f330354c19b1c16fae68122028e44503647669cd650b62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752671040,
      "headline": "GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain?",
      "id": 135993609,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Globus Medical debuts DuraPro with Excelsius integration, boosting its Power Portfolio.",
      "url": "https://finnhub.io/api/news?id=8354667fc340f432e5f330354c19b1c16fae68122028e44503647669cd650b62"
    }
  },
  {
    "ts": null,
    "headline": "Should You Continue to Hold Veracyte Stock in Your Portfolio Now?",
    "summary": "VCYT's Decipher growth and strong cash position bolster its outlook, but Biopharma headwinds and macro risks loom.",
    "url": "https://finnhub.io/api/news?id=e88f85408442ec3b5a11524e99146c2b83960a20ad191c1c3e6232392dfaa407",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752669480,
      "headline": "Should You Continue to Hold Veracyte Stock in Your Portfolio Now?",
      "id": 135994177,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "VCYT's Decipher growth and strong cash position bolster its outlook, but Biopharma headwinds and macro risks loom.",
      "url": "https://finnhub.io/api/news?id=e88f85408442ec3b5a11524e99146c2b83960a20ad191c1c3e6232392dfaa407"
    }
  },
  {
    "ts": null,
    "headline": "Is it Prudent to Retain Charles River Stock in Your Portfolio Now?",
    "summary": "CRL sees momentum in drug discovery and safety services, but macro pressures and currency headwinds threaten growth.",
    "url": "https://finnhub.io/api/news?id=7c53d43414a64052082c19c7a3b064035ee7794d7d88eeae868ae16d1b5d633a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752668340,
      "headline": "Is it Prudent to Retain Charles River Stock in Your Portfolio Now?",
      "id": 135966617,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "CRL sees momentum in drug discovery and safety services, but macro pressures and currency headwinds threaten growth.",
      "url": "https://finnhub.io/api/news?id=7c53d43414a64052082c19c7a3b064035ee7794d7d88eeae868ae16d1b5d633a"
    }
  },
  {
    "ts": null,
    "headline": "Should Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) Be on Your Investing Radar?",
    "summary": "Style Box ETF report for FLQM",
    "url": "https://finnhub.io/api/news?id=64ecb9fc30a7eb90f575d23d6221318fe76bf137d9e6fe02aed1d62a4f8ec6cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752661204,
      "headline": "Should Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) Be on Your Investing Radar?",
      "id": 135965945,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Style Box ETF report for FLQM",
      "url": "https://finnhub.io/api/news?id=64ecb9fc30a7eb90f575d23d6221318fe76bf137d9e6fe02aed1d62a4f8ec6cf"
    }
  }
]